×
Inari Medical Receivables 2019-2024 | NARI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Inari Medical receivables from 2019 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Inari Medical Receivables 2019-2024 | NARI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Inari Medical receivables from 2019 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$194.7B
Intuitive Surgical (ISRG)
$191.9B
Alcon (ALC)
$42.1B
Edwards Lifesciences (EW)
$41.4B
IQVIA Holdings (IQV)
$34.7B
IDEXX Laboratories (IDXX)
$34.1B
DexCom (DXCM)
$29.2B
STERIS (STE)
$20.9B
Waters (WAT)
$20.5B
SONOVA HOLDING (SONVY)
$20.3B
Hologic (HOLX)
$18.2B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.7B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.1B
Teleflex (TFX)
$9B
Masimo (MASI)
$8.8B
Glaukos (GKOS)
$8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.5B
Veracyte (VCYT)
$3B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.8B
Nihon Kohden (NHNKY)
$2.3B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$1.8B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B
Artivion (AORT)
$1.1B